Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Eris Lifesciences Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
Net Profit/Loss Before Extraordinary Items And Tax488.87431.24404.64442.20394.50
      
Net CashFlow From Operating Activities1065.01486.01291.74378.26375.36
Net Cash Used In Investing Activities-79.97-1854.52-982.10-319.61-323.36
Net Cash Used From Financing Activities-881.321379.78688.03-44.70-82.40
Adjustments On Amalgamation / Merger / Demerger And Others1.770.007.490.000.00
      
Net Inc/Dec In Cash And Cash Equivalents105.4911.265.1513.96-30.39
Cash And Cash Equivalents Begin of Year94.2582.9850.8736.9267.31
Cash And Cash Equivalents End Of Year199.7494.2556.0250.8736.92
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
Net Profit/Loss Before Extraordinary Items And Tax488.87
Net CashFlow From Operating Activities1065.01
Net Cash Used In Investing Activities-79.97
Net Cash Used From Financing Activities-881.32
Adjustments On Amalgamation / Merger / Demerger And Others1.77
Net Inc/Dec In Cash And Cash Equivalents105.49
Cash And Cash Equivalents Begin of Year94.25
Cash And Cash Equivalents End Of Year199.74